Coronavirus Update: Lilly To Seek EUA For Olumiant
Plus: Gilead Agrees European Procurement Deal On Veklury
Hot on the heels of positive news from its monoclonal antibody treatment, Lilly aims to seek emergency authorization for anti-inflammatory treatment Olumiant.
